Clinical Trial Update: RCT of Nintedanib in Fibrotic Sarcoidosis [Phase 4]

View source ↗

Summary

Nintedanib is being evaluated in a Phase 4 randomized trial for fibrotic sarcoidosis, and the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoidosis

Drugs mentioned

• Nintedanib (nintedanib)

Snippet

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh | Conditions: Sarcoidosis, Pulmonary | Phase 4 | Status: RECRUITING